Celgene: KarMMa-3 Ph3 Randomized bb2121 vs Standard regimen in RRMM (Multiple Myeloma) - Clinical Trial
What is the Purpose of this Study?
Who Can Participate in the Study?
Adults who have Relapsed/Refractory Multiple Myeloma
What is Involved?
If you chose to be in the study you will:
- Have a physical exam
- Take a memory test
- Give blood and urine samples
- Complete questionnaires
- Be randomized (like flipping a coin) to take the study drug bb2121 or the standard treatment
- Get x-rays of body